Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Medicalised homecare across Europe: who uses it the most?

We take a look at medicalised homecare user rates across Europe, which reflect the take-up of specialised medical treatment in the home by the whole population and give us interesting insights into how numerous markets operate: France, Iceland and Benelux use it far more than anyone else.

OECD imaging data shows stark differences in usage

The OECD's data on imaging examinations per-person and per-machine show massive gulfs in levels of usage, as well as the concentration of the sector outside of the hospital setting in Germany and France.

FREE BLOG For-profit healthcare, a necessary evil in NHS systems?

In a lot of Western European countries, especially where there is a national health service funded by taxation, for-profit healthcare providers are seen at best as a necessary evil by government. Or at least, that is what they would have you believe.

How extensive is NHI coverage in emerging markets?

As governments in South Africa and Uganda are preparing to put national health insurance (NHI) bills to parliaments, HBI looks at schemes already in place and the extent of coverage based on the latest available data.

FREE BLOG Finnish elderly care: under pressure and underfunded?

Finnish elderly care has been making headlines for the wrong reasons recently. Investors were left unimpressed by Attendo's Q2 results last Friday (July 19) which showed it making a loss. Its share price has almost halved since January. But it is not just Attendo feeling the heat - these are troubling times for other large operators in the Finnish elderly care market.  The CEO of Esperi Care, Finland's second wealthiest woman Marja Aarnio-Isohanni, resigned earlier this year after the country's healthcare watchdog temporarily shut down one of its facilities. Why are providers struggling in a market in desperate need of capacity?

FREE BLOG PMI and out of pocket boosts for-profit oncology in UK, Romania and India

Rates of growth vary dramatically in the for-profit oncology with mature markets with large outpatient radiotherapy sectors in France and Germany being left standing by growth rates in Emerging Markets such as India according to the latest report from HBI Intelligence. Surprisingly, the UK is also growing at 10%. 

FREE BLOG Genetic or genomic: Is bigger always better?

There are two types of testing: genetic and genomic. Genome sequencing reads each one of the three billion base pairs crammed into 23 chromosomes and their inter-relationships. Genetic testing doesn't. The two lend themselves to very different markets and produce different results. What does this mean for operators and patients?

Find Us